Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trial.

European radiology·2026
Same author

Hyperventilation-Induced Coronary Vasospasm in an Asthmatic Patient With ST-Segment Elevation and Intramyocardial Hematoma.

JACC. Case reports·2026
Same author

The Heart of the Matter: Cardiac PoCUS and the Hemodynamic Logic of Vascular Access.

Cardiorenal medicine·2026
Same author

The role of post-systolic strain and electrocardiographic changes during dobutamine stress echocardiography in enhancing detection of symptomatic coronary artery disease.

Frontiers in cardiovascular medicine·2025
Same author

Cardiac ultrasound in cardiovascular emergency and critical care: a clinical consensus statement of the European Association of Cardiovascular Imaging, the Acute CardioVascular Care Association of the European Society of Cardiology, and the European Association of Cardiothoracic Anaesthesia and Intensive Care.

European heart journal. Cardiovascular Imaging·2025
Same author

Mechanical dispersion predicts survival of dialysis-dependent patients with preserved left ventricular ejection fraction.

Internal and emergency medicine·2025

Related Experiment Video

Updated: Jul 19, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

[Atherosclerosis plaque regression].

Srdan D Bosković1, Aleksandar N Nesković

  • 1Univerzitet u Beogradu, Medicinski fakultet, Beograd. boskovics@hotmail.com

Medicinski Pregled
|October 31, 2006
PubMed
Summary

Statins can slow atherosclerosis progression and may even reverse it, particularly in early stages. These cholesterol-lowering drugs offer significant cardiovascular benefits.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Medical Imaging

Context:

  • Atherosclerosis progression is assessed via various imaging techniques.
  • Human atherosclerosis regression studies are a recent development (last 20 years).
  • Numerous interventions, including diet, exercise, and medications, have been studied.

Purpose:

  • To review the current understanding of atherosclerosis progression and regression.
  • To highlight the role of statins in managing atherosclerosis.
  • To discuss the potential of statins to induce atherosclerosis regression.

Summary:

  • Statins are established to slow atherosclerosis progression in patients with and without diagnosed coronary artery disease.
  • Their effects stem from metabolic and pleiotropic properties, contributing to reduced cardiovascular mortality and morbidity.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Related Experiment Videos

Last Updated: Jul 19, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

  • High-dose statin therapy may induce actual atherosclerosis regression, especially in asymptomatic individuals in early disease stages.

    • Impact:

    • Provides insights into the therapeutic potential of statins for atherosclerosis.
    • Informs clinical practice regarding the use of statins for cardiovascular risk reduction.
    • Suggests statins as a viable option for inducing atherosclerosis regression in specific patient populations.